Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
PETROCHINA
00857
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -15.17%36.78K | 12.66%16.69K | -47.25%3.63K | 15.45%7.2K | -39.35%9.26K | -75.99%43.36K | -52.91%14.82K | -92.16%6.87K | -24.30%6.24K | -73.23%15.27K |
| Selling and administrative expenses | -16.80%22.11K | -7.14%13K | -50.00%3K | 31.07%3.11K | -28.57%3K | -75.09%26.57K | 61.64%14K | -92.00%6K | 54.53%2.37K | -90.52%4.2K |
| -General and administrative expense | -16.80%22.11K | -7.14%13K | -50.00%3K | 31.07%3.11K | -28.57%3K | -75.09%26.57K | 61.64%14K | -92.00%6K | 54.53%2.37K | -90.52%4.2K |
| Research and development costs | ---- | ---- | ---- | ---- | --0 | -90.57%4.61K | -100.01%-1 | --0 | --0 | --4.61K |
| Other operating expenses | -12.60%14.68K | 352.33%3.69K | -28.33%625 | 5.89%4.1K | -43.44%6.26K | -77.30%16.79K | -96.42%816 | -93.08%872 | -42.31%3.87K | -13.23%11.07K |
| Operating profit | 15.17%-36.78K | -12.66%-16.69K | 47.25%-3.63K | -15.45%-7.2K | 39.35%-9.26K | 75.99%-43.36K | 52.91%-14.82K | 92.16%-6.87K | 24.30%-6.24K | 73.23%-15.27K |
| Net non-operating interest income (expenses) | -47.46%6.09K | -47.60%1.21K | -55.00%1.35K | -54.18%1.44K | -33.33%2.08K | -4.39%11.59K | -35.15%2.32K | -35.61%3K | -19.62%3.15K | 11,666.67%3.12K |
| Non-operating interest income | -47.46%6.09K | -47.60%1.21K | -55.00%1.35K | -54.18%1.44K | -33.33%2.08K | -4.39%11.59K | -32.15%2.32K | -36.24%3K | -21.33%3.15K | --3.12K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -82.61%8 | 82.35%155 | -70.37%8 |
| Other net income (expenses) | ||||||||||
| Income before tax | 3.40%-30.69K | -23.81%-15.48K | 41.24%-2.28K | -86.29%-5.76K | 40.89%-7.18K | 81.14%-31.78K | 55.18%-12.5K | 95.33%-3.87K | 28.54%-3.09K | 78.72%-12.15K |
| Income tax | 0 | 0 | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 3.40%-30.69K | -23.81%-15.48K | 41.24%-2.28K | -86.29%-5.76K | 40.89%-7.18K | 81.14%-31.78K | 55.18%-12.5K | 95.33%-3.87K | 28.54%-3.09K | 78.72%-12.15K |
| Net income continuous operations | 3.40%-30.69K | -23.81%-15.48K | 41.24%-2.28K | -86.29%-5.76K | 40.89%-7.18K | 81.14%-31.78K | 55.18%-12.5K | 95.33%-3.87K | 28.54%-3.09K | 78.72%-12.15K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 3.40%-30.69K | -23.81%-15.48K | 41.24%-2.28K | -86.29%-5.76K | 40.89%-7.18K | 81.14%-31.78K | 55.18%-12.5K | 95.33%-3.87K | 28.54%-3.09K | 78.72%-12.15K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 3.40%-30.69K | -23.81%-15.48K | 41.24%-2.28K | -86.29%-5.76K | 40.89%-7.18K | 81.14%-31.78K | 55.18%-12.5K | 95.33%-3.87K | 28.54%-3.09K | 78.72%-12.15K |
| Diluted earnings per share | 0.00%-0.003 | 0.00%-0.001 | 0 | -0.001 | 0.00%-0.001 | 85.00%-0.003 | 50.00%-0.001 | 0 | 0 | 87.50%-0.001 |
| Basic earnings per share | 0.00%-0.003 | 0.00%-0.001 | 0 | -0.001 | 0.00%-0.001 | 85.00%-0.003 | 50.00%-0.001 | 0 | 0 | 87.50%-0.001 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.